Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study

[1] Dong E(2020)An interactive web-based dashboard to track COVID-19 in real time Lancet Infect Dis 20 533-534

[2] Du H(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet (London, England) 395 497-506

[3] Gardner L(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet (London, England) 395 507-513

[4] Huang C(2020)Coronavirus disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German cardiac society and the world heart federation Clinic Res Cardiol: Off J German Cardiac Soc 109 1446-1459

[5] Chen N(2020)Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan China JAMA cardiology 5 802-810

[6] Böhm M(2020)Characteristics and outcomes of 21 critically Ill patients With COVID-19 in Washington State JAMA 323 1612-1614

[7] Shi S(2020)Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA cardiology 5 811-818

[8] Arentz M(2020)Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications Eur J Heart Fail 22 2205-2215

[9] Guo T(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet (London, England) 395 1054-1062

[10] Rey JR(2020)The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2 Cardiovasc Res 116 1097-1100

[1] Dong E(2020)An interactive web-based dashboard to track COVID-19 in real time Lancet Infect Dis 20 533-534

[2] Du H(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet (London, England) 395 497-506

[3] Gardner L(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet (London, England) 395 507-513

[4] Huang C(2020)Coronavirus disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German cardiac society and the world heart federation Clinic Res Cardiol: Off J German Cardiac Soc 109 1446-1459

[5] Chen N(2020)Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan China JAMA cardiology 5 802-810

[6] Böhm M(2020)Characteristics and outcomes of 21 critically Ill patients With COVID-19 in Washington State JAMA 323 1612-1614

[7] Shi S(2020)Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA cardiology 5 811-818

[8] Arentz M(2020)Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications Eur J Heart Fail 22 2205-2215

[9] Guo T(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet (London, England) 395 1054-1062

[10] Rey JR(2020)The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2 Cardiovasc Res 116 1097-1100